Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis.


BACKGROUND AND AIM Patients infected with hepatitis C virus (HCV) often develop chronic liver disease, liver cirrhosis and concurrent thrombocytopenia, which manifests as decreased platelet counts and bleeding complications. Romiplostim, a thrombopoietin mimetic peptibody that stimulates the thrombopoietin receptor, has been used as a treatment for primary… (More)
DOI: 10.1111/j.1440-1746.2012.07246.x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics